Raymond Miao

548 total citations
26 papers, 426 citations indexed

About

Raymond Miao is a scholar working on Pulmonary and Respiratory Medicine, Radiology, Nuclear Medicine and Imaging and Endocrinology, Diabetes and Metabolism. According to data from OpenAlex, Raymond Miao has authored 26 papers receiving a total of 426 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Pulmonary and Respiratory Medicine, 8 papers in Radiology, Nuclear Medicine and Imaging and 8 papers in Endocrinology, Diabetes and Metabolism. Recurrent topics in Raymond Miao's work include Prostate Cancer Treatment and Research (9 papers), Radiopharmaceutical Chemistry and Applications (7 papers) and Diabetes Management and Research (7 papers). Raymond Miao is often cited by papers focused on Prostate Cancer Treatment and Research (9 papers), Radiopharmaceutical Chemistry and Applications (7 papers) and Diabetes Management and Research (7 papers). Raymond Miao collaborates with scholars based in United States, Canada and China. Raymond Miao's co-authors include Wenhui Wei, Li Wang, Onur Başer, Francis Vekeman, Jingdong Chao, Lin Xie, Hüseyin Yüce, Marjolaine Gauthier‐Loiselle, William Oh and Wendy Y. Cheng and has published in prestigious journals such as Journal of Clinical Oncology, Blood and PLoS ONE.

In The Last Decade

Raymond Miao

25 papers receiving 418 citations

Peers

Countries citing papers authored by Raymond Miao

Since Specialization

Citations

This map shows the geographic impact of Raymond Miao's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Raymond Miao with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Raymond Miao more than expected).

Fields of papers citing papers by Raymond Miao

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Raymond Miao. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Raymond Miao. The network helps show where Raymond Miao may publish in the future.

Co-authorship network of co-authors of Raymond Miao

This figure shows the co-authorship network connecting the top 25 collaborators of Raymond Miao. A scholar is included among the top collaborators of Raymond Miao based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Raymond Miao. Raymond Miao is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Spatial‒temporal heterogeneities of liver cancer and the discovery of the invasive zone 2025 ·Clinical and Translational Medicine ·Jiayan Yan, (unknown), Shiyu Zhang, Qichao Yu, Yijun Lu, Raymond Miao, Zhao–You Tang, (unknown), Liang Wu, Dan G. Duda, Jian Zhou, Xin‐Rong Yang	2
2	Global burden of antimicrobial resistance in lower respiratory infections in 2021: A systematic analysis 2024 ·International Journal of Antimicrobial Agents ·(unknown), Raymond Miao, Ning Zhang, (unknown), Zhengyang Wu, Haiwei Wang, Yang� Yang, (unknown), Yan Du	2
3	Effects of variations in access to care for children with atopic dermatitis 2020 ·BMC Dermatology ·Elaine C. Siegfried, Amy S. Paller, Paola Mina‐Osorio, Francis Vekeman, Mandeep Kaur, Usha G. Mallya, Julie Héroux, Raymond Miao, Abhijit Gadkari	28
4	692 Real-world effectiveness of dupilumab based on Investigator Global Assessment (IGA) and peak Pruritus Numerical Rating Scale (PNRS) scores 2019 ·Journal of Investigative Dermatology ·Lawrence F. Eichenfield, A. Gadkari, April W. Armstrong, Emma Guttman‐Yassky, Peter Lio, (unknown), (unknown), Claire McGuinness, Miriam C. Fenton, Raymond Miao, Z. Chen, Mandeep Kaur, Andrew Korotzer, (unknown)	1
5	Real-world utilization patterns of systemic immunosuppressants among US adult patients with atopic dermatitis 2019 ·PLoS ONE ·April W. Armstrong, (unknown), Li Wang, Raymond Miao, M. PATEL, Abhijit Gadkari, Usha G. Mallya, Jingdong Chao	26
6	Treatment patterns of pediatric patients with atopic dermatitis: A claims data analysis 2019 ·Journal of the American Academy of Dermatology ·Amy S. Paller, Elaine C. Siegfried, Francis Vekeman, Abhijit Gadkari, Mandeep Kaur, Usha G. Mallya, Julie Héroux, Raymond Miao, Paola Mina‐Osorio	23
7	Real-world outcomes in patients with metastatic castration-resistant prostate cancer receiving second-line chemotherapy versus an alternative androgen receptor-targeted agent (ARTA) following early progression on a first-line ARTA in a US community oncology setting 2018 ·Urologic Oncology Seminars and Original Investigations ·William Oh, Wendy Y. Cheng, Raymond Miao, Francis Vekeman, Marjolaine Gauthier‐Loiselle, Mei Sheng Duh, Edward J. Drea, Ted P. Szatrowski	37
8	Burden of Atopic Dermatitis in the United States: Analysis of Healthcare Claims Data in the Commercial, Medicare, and Medi-Cal Databases 2017 ·Advances in Therapy ·(unknown), Raymond Miao, Li Wang, Jingdong Chao, Hüseyin Yüce, Wenhui Wei	66
9	243 Real world systemic corticosteroid (SCS) utilization patterns and costs in adult patients with atopic dermatitis (AD) 2017 ·Journal of Investigative Dermatology ·April W. Armstrong, Wenhui Wei, Raymond Miao, M. PATEL, Adam Huang, Liping Wang, J. Chao	0
10	Patient characteristics and overall survival in patients with post-docetaxel metastatic castration-resistant prostate cancer in the community setting 2017 ·Medical Oncology ·William Oh, Raymond Miao, Francis Vekeman, Jennifer Sung, Wendy Y. Cheng, Marjolaine Gauthier‐Loiselle, Ravinder Dhawan, Mei Sheng Duh	15
11	Real-world Characteristics and Outcomes of Patients With Metastatic Castration-resistant Prostate Cancer Receiving Chemotherapy Versus Androgen Receptor-targeted Therapy After Failure of First-line Androgen Receptor-targeted Therapy in the Community Setting 2017 ·Clinical Genitourinary Cancer ·William Oh, Raymond Miao, Francis Vekeman, Jennifer Sung, Wendy Y. Cheng, Marjolaine Gauthier‐Loiselle, Ravinder Dhawan, Mei Sheng Duh	27
12	Budgetary Impact of Cabazitaxel Use After Docetaxel Treatment for Metastatic Castration-Resistant Prostate Cancer 2017 ·Journal of Managed Care & Specialty Pharmacy ·(unknown), (unknown), (unknown), Shelby Corman, Xin Gao, Mei Xue, Raymond Miao	14
13	Real-world outcomes in patients (pts) with metastatic castration-resistant prostate cancer (mCRPC) receiving second-line (2L) chemotherapy (CT) vs alternative androgen receptor-targeted agents (ARTA) after lack of response to first-line (1L) ARTA in US community oncology practices. 2017 ·Journal of Clinical Oncology ·William Oh, Wendy Y. Cheng, Raymond Miao, Francis Vekeman, Marjolaine Gauthier‐Loiselle, Mei Sheng Duh, Edward J. Drea, Ted P. Szatrowski	2
14	A common data model to assess cardiovascular hospitalization and mortality in atrial fibrillation patients using administrative claims and medical records 2015 ·Clinical Epidemiology ·Mary Panaccio, (unknown), Charles Wentworth, Stephan Lanes, (unknown), Matthew Reynolds, Raymond Miao, Andrew Koren	11
15	Much Ado About Nothing? A Real-World Study of Patients with Type 2 Diabetes Switching Basal Insulin Analogs 2014 ·Advances in Therapy ·Wenhui Wei, Steve Zhou, Raymond Miao, Chunshen Pan, Lin Xie, Onur Başer, (unknown)	19
16	Does Device Make Any Difference? A Real-world Retrospective Study of Insulin Treatment Among Elderly Patients With Type 2 Diabetes 2014 ·Journal of Diabetes Science and Technology ·Raymond Miao, Wenhui Wei, Jay Lin, Lin Xie, Onur Başer	18
17	Real-world outcomes of US employees with type 2 diabetes mellitus treated with insulin glargine or neutral protamine Hagedorn insulin: a comparative retrospective database study 2013 ·BMJ Open ·Li Wang, Wenhui Wei, Raymond Miao, Lin Xie, Onur Başer	35
18	Does device matter and at what cost? real-world comparative study of insulin glargine treatment using disposable pen versus vial/syringe in medicaid patients with type-2 diabetes mellitus 2013 ·Value in Health ·Zhun Cao, Emma C. Thomson, Ling Zou, Raymond Miao, Wenhui Wei	1
19	Real world outcomes of adding rapid-acting insulin versus switching to analog premix insulin among US patients with type 2 diabetes treated with insulin glargine 2013 ·Patient Preference and Adherence ·Raymond Miao, Wenhui Wei, Onur Başer, Lin Xie	15
20	Higher Incidence of Venous Thromboembolism in the Outpatient Versus the Inpatient Setting Among U.S. Cancer Patients 2011 ·Blood ·Alok A. Khorana, Mehul Dalal, Krishna Tangirala, Raymond Miao	18

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact